Repligen (RGEN) Reports Q4 Loss of $0.09, Misses by 3c

June 11, 2009 7:53 AM EDT

Repligen Corporation (Nasdaq: RGEN) reports Q4 loss of $0.09, 3 cents lower than the analyst estimate of ($0.06). Revenue for the quarter was $4.59 million, versus the consensus of $5 million.


Related Categories

Earnings

Stocks Mentioned

RGEN 4.92

+0.03 +0.61%
Volume: 62,099
Track RGEN


Add Your Comment